Scott Brun
Head @ AbbVie
Chicago, United States
Scott Brun is a venture - series unknown investor at AbbVie in Chicago focused on Medical and Hospital. Scott Brun is the President at Gold Mast Consulting. In addition to his role in AbbVie Ventures, Scott is Vice President, Scientific Affairs, and acts as an Abbvie spokesperson on R&D matters to global media, governmental officials, and institutional investors. Prior to this role, Scott led Pharmaceutical Development at AbbVie and wasresponsible for advancing a broad pipeline across several therapeutic areas. In his 20+ year career at Abbott/AbbVie, he held roles of increasing responsibility across the research and development organization.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Scott Brun invests in
Stages Scott Brun invests in
Countries Scott Brun invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (100%)
- Hospital 1 (100%)
- Health Care 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Aquinnah Pharmaceuticals is focused on an exciting new area of research and development to modulate neurodegenerative stress granules, believed to be important in the pathology of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. | $10M / Venture - Series Unknown / Apr 25, 2017 |
Co-Investors
About AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVieemploys approximately 21,000 people worldwide and markets medicines in more than 170 countries.
AbbVie Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Melissa A. Walsh
Vice President, State Government Affairs
|
|||
Will Haines
Field Director - Oncology Medical Science Liaisons
|
|||
Amanda Graber Rosenberg
Global Communications Strategy & Planning
|
|||
Arminda Montero
Program Manager, Global Supply Chain QA
|
|||
Henry Gosebruch
EVP and Chief Strategy Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Scott Brun invest in?
Scott Brun invests primarily in Medical, Hospital and Health Care startups, most often at Venture - Series Unknown stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Scott Brun?
Public channels for Scott Brun include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Scott Brun last invest?
The most recent investment recorded for Scott Brun closed in Apr 2017. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
